Cytokine levels in cerebrospinal fluid and delayed ischemic deficits in patients with aneurysmal subarachnoid hemorrhage. by Kwon, K. Y. & Jeon, B. C.
INTRODUCTION
Cerebral vasospasm following subarachnoid hemorrhage
(SAH) due to a ruptured aneurysm is an important cause of
cerebral ischemia, and is the leading cause of death and dis-
ability after aneurysmal rupture (1-3). The pathogenesis of
this condition is poorly understood, and many studies have
failed to yield conclusive evidence as to the causative agent
or the nature of the cerebral arterial narrowing (1, 2, 4-9).
Immune responses including cytokines are involved in
the pathogenesis of cerebral vasospasm following aneurys-
mal SAH (10, 11). Localized brain immune responses lead
to increased levels of the immunomodulators, “cytokines” .
In experimental ischemia, the proinflammatory cytokine
interleukin-1 (IL-1) mediates cellular damage and an IL-1
antagonist reduce brain damage after episode of temporary
ischemia (11). Interleukin-6 (IL-6) is significantly increased
in patients suffering from a delayed ischemic deficit follow-
ing SAH (11). Interleukin-1 receptor antagonist (IL-1Ra)
and tumor necrosis factor- (TNF- ) are also increased fol-
lowing SAH. IL-1 and TNF- are known to cause or con-
tribute to experimental ischemic and traumatic brain injury
(12).
Cho et al. (13) reported that increased levels of IL-1 , IL-
6, IL-8, and TNF- could be highly suggestive of meningi-
tis. IL-1 production in the central nervous system (CNS)
following SAH has not been studied. In addition, the initial
levels of cerebrospinal fluid (CSF) cytokines including IL-1 ,
IL-6, and TNF- contributing to delayed ischemic deficit
(DID) have not been studied. On the basis of the known
association of SAH and various cytokines, this study was
undertaken to investigate whether DID could be predicted
by the high levels of  cytokines including IL-1 , IL-6, and
TNF- in the initial CSF following SAH (10, 11).
MATERIALS AND METHODS
Nineteen patients (Table 1) suffering from aneurysmal
SAH were the subjects in this study. CSF samples were ob-
tained at emergency room, less than 24 hr after attack. CSF
was obtained in 12 patients undergoing induction of spinal
anesthesia for surgery of inguinal hernia. These 12 patients
served as control volunteers (Table 2). Each CSF sample was
immediately centrifuged and stored at -80℃until analysis.
The level of each cytokine was analyzed with enzyme-
linked immunosorbent assay (ELISA) (supplied by Diaclone
Research, Besancon, France). Incubations of CSF and stan-
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Cytokine Levels in Cerebrospinal Fluid and Delayed Ischemic Deficits
in Patients with Aneurysmal Subarachnoid Hemorrhage
Subarachnoid hemorrhage (SAH) induces an inflammatory reaction and may
lead to ischemic brain damage. The pathogenesis of brain dysfunction and
delayed ischemic symptoms remain difficult to understand despite extensive
surveys of such reactions. Cytokine production in the central nervous system fol-
lowing SAH and its relation with clinical outcome have hardly been studied. This
study was aimed to determine whether the levels of IL-1 , IL-6 and TNF- in the
initial cerebrospinal fluid would increase following aneurysmal SAH, and be
related with development of delayed ischemic deficit and clinical outcome. Nine-
teen patients suffering from aneurysmal SAH and 12 control volunteers were
the subjects in this study. Cerebrospinal fluid samples were obtained on admis-
sion and the levels of each cytokine were determined with enzyme-linked
immunosorbent assay. Patients with aneurysmal subarachnoid hemorrhage
showed elevated levels of IL-1 ‚ and TNF- on admission. The patients with
poor neurological status showed high levels of IL-1 ‚ and IL-6. The patients who
developed delayed ischemic deficit had high level of IL-6. We suggest that ele-
vated level of IL-6 in cerebrospinal fluid of patients with aneurysmal SAH on
admission can predict the high risk of delayed ischemic deficit.
Key Words : Cytokines; Interleukin-1, Interleukin-6, Tumor Necrosis Factor; Subarachnoid Hemor-
rhage, Delayed Ischemic Deficit 
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Accepted : 9 July 2001dards with conjugates were performed according to the
instructions of the manufacturer, using only half the vol-
umes. Substrate activation by horseradish peroxidase was
determined by chemiluminescence (Microplate reader man-
ufactured by Bio-Rad Inc., Japan). Tetramethylbenzidine
(100  L, 0.1 mg/L) was added and the solution was incu-
bated for 20 min. The plate was then placed in a luminome-
ter and 50  L of 6 mM Na Luminol (supplied by Diaclone
Research, Inc., Besancon, France) which had been recrystal-
lized three times and stabilized with hydrogen peroxide, was
added to each well. Emitted light was measured by means
of a photomultiplier with a spectral response of 450 to 620
nm. The signal was measured at a peak over a total time
period of 1 second. Light signals over background values
were detected linearly related in a log scale in the 15.6 to
500 pg/mL interval of IL-1 , 6.25 to 200 pg/mL interval of
IL-6 and 25 to 800 pg/mL interval of TNF- in standard
curve.
All patients were treated with early surgery, nimodipine,
and intensive  “triple H” therapy (hypervolemia, hyperten-
sion, and hemodilution). All operations were performed by
a single neurosurgeon (BCJ) so as to exclude operator-related
variation.
The level of each cytokine in SAH patients was compared
with that of control volunteers. The level of each cytokine
was analyzed in relation to various parameters, such as neu-
rological status on admission, amount of SAH on comput-
erized tomographic (CT) scan, development of DID and
clinical outcome. The patients’ neurological status on admis-
sion were classified according to Hunt and Hess grading
(HHG). HHG score of 1 to 3 was regarded as low-grade
group, suggesting relatively good neurological condition.
HHG score of 4 or 5 was regarded as high-grade group,
suggesting poor neurological condition. Amount of SAH
on CT scan was classified according to Fisher’ s grade (FG).
FG score of 1 to 2 was regarded as low-grade group, indi-
cating small amount of hemorrhage on a CT scan and FG
score of 3 to 4 was regarded as high-grade group, indicating
large amount of hemorrhage on a CT scan. All patients took
CT scan at 14th day after SAH to find out radiological evi-
dence of DID. The patients who developed DID were com-
pared with those without DID. Clinical outcome was classi-
fied according to Glasgow outcome scale (GOS). GOS score
of 4 to 5 was regarded as favorable outcome and GOS score
of 1 to 3 was regarded as unfavorable outcome.
The ages of the patients ranged from 34 to 69 yr (mean,
51.7 yr). Five patients were over sixty years. Six patients were
men and 13 patients were women. The aneurysmal rupture
in nine cases developed at anterior communicating artery.
Sixteen patients presented with low HHG, others with high
HHG. Eleven patients showed high FG. Six patients devel-
oped DID. Fourteen patients had favorable outcome and
others had unfavorable outcome (Table 1).
Statistical analyses were done using Mann-Whitney U-test
(p<0.05). Analyses were performed using IBM compatible
computers (Sambo computer Inc., Seoul, Korea) and SPSS
software (SPSS Inc., U.S.A.).
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No. Age (yr)/Sex IL-1
(pg/mL)
IL-6 (pg/mL) TNF-
(pg/mL)
1 47/F 0.1 589.1 7.5
2 36/M 3.2 804.4 4.2
3 52/M 0.2 676.6 2.1
4 65/F 0.9 484.9 8.4
5 29/M 0.1 552.7 11.7
6 42/F 0.1 436.6 7.2
7 38/F 0.1 641.8 10.5
8 45/M 1.0 228.5 0.2
9 46/M 0.5 522.9 0.2
10 58/F 0.1 206.2 0.2
11 53/F 0.1 157.0 0.2
12 47/F 0.1 204.0 0.2
Mean±SD 46.5 0.54±0.90 458.73±214.11 4.38±4.45
Table 2. CSF cytokine levels of control volunteers
Age (yr)/
Sex
Case 
No.
Aneurysm* FG
� HHG
� DID GOS
�
1 56/F Acom 4 3 no 3
2 69/F MCA 3 4 no 5
3 36/M Pcom 2 1 yes 4
4 34/F MCA 1 2 no 5
5 47/M Acom 3 3 yes 4
6 56/F ICA 2 3 no 4
7 62/M Acom 2 3 no 5
8 64/F Pcom 3 2 yes 3
9 48/M Acom 3 2 no 5
10 52/F Pcom 4 2 yes 2
11 44/F VA 3 2 no 4
12 38/F Acom 2 3 no 5
13 47/F MCA 3 4 no 5
14 58/M Acom 3 3 yes 4
15 49/F Pcom 2 3 no 5
16 73/F Acom 4 3 no 1
17 51/M Acom 1 1 yes 3
18 42/F Pcom 2 1 no 5
19 56/F DACA 3 3 no 5
Table 1. Clinical characteristics of 19 patients with subarach-
noid hemorrhage
*Aneurysm: Acom; anterior communicating artery, MCA; middle cere-
bral artery, ICA; internal carotid artery, Pcom; posterior communicating
artery, VA; vertebral artery, DACA; distal anterior cerebral artery. 
� Hunt
and Hess grade (14) 1. asymptomatic or minimal headache and slight
nuchal rigidity. 2. moderate to severe headache, nuchal rigidity, no
neurological deficit other than cranial nerve palsy. 3. drowsiness, con-
fusion, or mild focal deficit. 4. stupor, moderate to severe hemiparesis,
possible early decerebrate rigidity and vegetative disturbances. 5.
deep coma, decerebrate rigidity, moribund appearance. 
� Fisher grade
(15) 1. no blood detected. 2. diffuse or vertical layers<1 mm thickness.
3. localized clot and/or vertical layer>1 mm thickness. 4. intracerebral
or intraventricular clot with diffuse or no SAH. 
�Glasgow outcome scale
(16). 1. death. 2. persistent vegetative state. 3. severe disability (con-
scious but disable). 4. moderate disability (disabled but independent).
5. good recoveryRESULTS
Cytokine levels of control volunteers
In control volunteers, the ages ranged from 29 to 65 yr
(mean, 46.5 yr). Seven were women, and five were men. The
variation of each cytokine was smaller than that in SAH pa-
tients. Mean values±SD for IL-1 , IL-6, and TNF- were
0.54±0.90 pg/mL, 458.73±214.11 pg/mL, 4.38±4.45
pg/mL, respectively (Table 2).
Cytokine levels of SAH patients
CSF samples from the 19 patients were analyzed for IL-1 ,
IL-6, and TNF- . A large variation in individual cytokine
value was found in SAH patients. Mean values±SD for IL-
1 , IL-6 and TNF- were 86.82±179.39 pg/mL, 630.15
±685.41 pg/mL, 42.98±30.08 pg/mL, respectively. The
mean values of IL-1 , IL-6 and TNF- increased compared
with controls. Three patients (cases 3, 6, and 8) had high
levels of IL-1 and two of them developed DID. Seven pa-
tients (cases 3, 5, 6, 8, 10, 14 and 17) had high levels of IL-
6 and 6 of them (cases 3, 5, 8, 14, and 17) developed DID.
Three of 6 patients who developed DID had poor outcome.
Three (cases 5, 6, and 14) of 7 patients who had high levels
of IL-6 showed a large amount of SAH (Table 3).
Comparison between SAH patients and control 
volunteers
Acording to the present study, the mean values of IL-1
and TNF- in SAH patients were around 10-fold higher
than those in healthy volunteers. A statistically significant
increase of the level was detected in IL-1 and in TNF-
(p<0.05, Mann-Whitney U test) in patients with SAH. The
mean value of IL-6 in SAH patients was higher than that in
healthy volunteers, but without a statistical significance (p>
0.05; Table 4).
Hunt and Hess grade
The mean value IL-1 in low HHG group (n=16) was
2.5±0.00 pg/mL. In high HHG group (n=3), the mean
value of IL-1 was 100.75±193.15 pg/mL which was
around 40-fold higher than that of low HHG group with a
statistical significance (p<0.05). For IL-6, the mean value in
low HHG group was 117.11±91.98 pg/mL. In high HHG
group, the mean value of IL-6 was 726.35±707.18 pg/mL,
which was around 6-fold higher than that of low HHG
group, but without a statistical significance (p>0.05). There
was no statistically significant difference between the levels
of TNF- in low HHG group and in high HHG group
(42.71±32.18 pg/mL and 44.44±19.25 pg/mL, respec-
tively; p>0.05; Table 5).
Fisher grade
The mean value of IL-1 in low FG group (n=8) was
134.36±255.63 pg/mL. In high FG group (n=11), the
mean value of IL-1 was 52.23±95.16 pg/mL, which was
around one third of that of low FG group, but without a
statistical significance (p>0.05). The mean value of IL-6 in
low FG group was 599.66±797.64 pg/mL. In high FG
group, the mean value of IL-6 was 652.33±631.65 pg/mL,
which was higher than that of low FG group, but without a
statistical significance (p>0.05). The mean value of TNF-
in low FG group was 47.92±38.25 pg/mL. In high FG
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Case No. IL-6 (pg/mL) IL-1 (pg/mL) TNF- (pg/mL)
1 12.5 148.64 33.33
2 25.0 40.54 16.67
3 750.0 1851.35 133.33
4 12.5 54.05 16.67
5 37.5 1310.81 16.67
6 337.5 1567.56 16.67
7 37.5 94.59 33.33
8 187.5 1216.21 33.33
9 25.0 67.56 33.33
10 12.5 1540.54 66.67
11 50.0 27.02 33.33
12 25.0 364.86 50.00
13 12.5 162.16 50.00
14 25.0 1297.29 100.00
15 12.5 13.51 50.00
16 12.5 189.18 33.33
17 12.5 1554.05 50.00
18 25.0 13.51 16.67
19 37.0 456.45 33.33
Mean±SD 86.82±179.39 630.15±685.41 42.98±30.08
Table 3. Cerebrospinal fluid cytokine levels of 19 patients with
subarachnoid hemorrhage
Cytokine Control (n=12) SAH* (n=19) p
�
IL-1 86.82±179.39 0.54±0.90 0.000
IL-6 630.15±685.41 458.73±214.11 0.441
TNF- 42.98±30.08 4.38±4.45 0.000
Table 4. Comparison of each CSF cytokine level between
patients with subarachnoid hemorrhage and control volunteers
*Subarachnoid hemorrhage; 
� Mann-Whitney U test (p<0.05)
Cytokine High HHG (n=3) Low HHG (n=16) p*
IL-1 2.5±0.00 100.75±193.15 0.037
IL-6 117.11±91.98 726.35±707.18 0.655
TNF- 42.71±32.18 44.44±19.25 0.561
Table 5. Comparison of Hunt and Hess grade with CSF
cytokine levels
*Mann-Whitney U test (p<0.05)group, the mean value of TNF- was 39.39±23.89 pg/mL,
which was lower than that of low FG group, but without a
statistical significance (p>0.05; Table 6). 
Delayed ischemic deficit
The mean value of IL-1 in DID group (n=6) was 170.83
±291.51 pg/mL. In non-DID group (n=13), the mean
value of IL-1 was 48.04±87.78 pg/mL. The mean value
of IL-1 in DID group was around 3-fold higher  than that
of non-DID group, but without a statistical significance
(p>0.05). The mean value of IL-6 in DID group was 1207.20
±629.14 pg/mL. In non-DID group, the mean value of IL-
6 was 363.82±544.45 pg/mL. The mean value of IL-6 in
DID group was around 4-fold higher than that of non-DID
group, and the difference was statistically significant (p<0.05).
The mean value of TNF- in DID group was 66.67±43.46
pg/mL. In non-DID group, the mean value of TNF- was
32.05±12.66 pg/mL, which was a half of that of DID group,
without statistical significance (p>0.05; Table 7).
Glasgow outcome scale
The mean value of IL-1 in unfavorable GOS group (n=5)
was 47.5±78.26 pg/mL. In favorable GOS group (n=14),
the mean value of IL-1 was 100.86±204.61 pg/mL, which
was higher than that of unfavorable GOS group, but with-
out a statistical significance (p>0.05). The mean value of IL-
6 in unfavorable GOS group was 623.32±707.71 pg/mL.
In favorable GOS group, the mean value of IL-6 was 632.24
±704.52 pg/mL, which was slightly higher than that of
the unfavorable (p>0.05). The mean value of TNF- in unfa-
vorable GOS group was 43.33±14.91 pg/mL. In favorable
GOS group, the mean value of TNF- was 42.86±34.41
pg/mL, which was slightly lower than that of unfavorable
GOS group (p>0.05; Table 8).
DISCUSSION
SAH induces cascading biochemical reactions and may
cause major brain damage (11). The pathogenesis of brain
dysfunction and delayed ischemic symptoms remain elusive
despite continuing investigations. A change in metabolism,
increased levels of excitatory amino acids, ischemic changes,
and inflammatory phenomena have been described. In addi-
tion, cerebral vasospasm, which often coexists with symp-
toms of delayed ischemia, has been thought to play a causative
role by some researchers. Cerebral vasospasm after SAH
results from vascular smooth muscle contraction and mor-
phologic changes related to inflammatory reactions (12, 17).
Inflammatory mechanisms appear to be important in caus-
ing symptoms of clinical deterioration and ischemic brain
damage following a SAH (11).
Most cytokines usually act over short distances as autocrine
or paracrine intercellular signals in local tissues. Experimen-
tal injuries caused an early production of cytokines (18). An-
other experimental brain contusion caused a delayed intrac-
erebral production of potent inflammatory cytokines such
as IL-1 , IL-6, and TNF- . An increase of the proinflam-
matory cytokines, IL-1 , IL-6, or TNF- was also detected
in the CSF of patients treated for severe brain injuries (10, 11,
19-22).
The inflammatory cytokines are differently released in the
intrathecal space infected with viruses or bacteria and per-
sistent increase of cytokines is associated with continued
disease activity (20). Each of concentrations of IL-1 , IL-6,
IL-8, and TNF- was significantly increased in the CSF of
patients with viral or Mycoplsma pneumoniae meningitis (13).
Both concentrations of IL-1 and TNF- were significant-
ly higher in the CSF of patients with bacterial meningitis
than in those with aseptic meningitis (19-21). Increased
serum TNF- concentration was associated with fatal out-
come in meningococcal septic shock (20, 21). A significant
correlation was found between TNF- concentration in the
CSF, and the consecutive febrile days or the occurrence of
seizures in bacterial meningitis (22). IL-1 and TNF- are
produced in the purulent CSF, and their concentrations may
be associated with the initial clinical status and the outcome
(20).
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Cytokine High FG* (n=11) Low FG* (n=8) p
�
IL-1 134.36±255.63 52.23±95.16 0.732
IL-6 599.66±797.64 652.33±631.65 0.967
TNF- 47.92±38.25 39.39±23.89 0.764
Table 6. Comparison of Fisher grade with CSF cytokine levels 
*Low FG: Fisher grade 1 and 2, high FG: Fisher grade 3 and 4; 
� Mann-
Whitney U test (p<0.05)
Cytokine no DID
�(n=13) DID* (n=6) p
�
IL-1 170.83±291.51 48.04±87.78 0.440
IL-6 1207.20±629.14 363.82±544.45 0.003
TNF- 66.67±43.46 32.05±12.66 0.062
Table 7. Comparison of delayed ischemic deficit with CSF
cytokine levels
*DID: development of delayed ischemic deficit; 
� no DID: no develop-
ment of delayed ischemic deficit; 
� Mann-Whitney U test (p<0.05)
Cytokine GOS (4-5, n=14) GOS* (1-3, n=5) p
�
IL-1 47.5±78.26 100.86±204.61 0.103
IL-6 623.32±707.71 632.24±704.52 0.195
TNF- 43.33±14.91 42.86±34.41 0.413
Table 8. Comparison of Glasgow outcome scale with CSF
cytokine levels
*GOS (1-3) was regarded as unfavorable outcome, GOS (4, 5) as
favorable outcome; 
� Mann-Whitney U test (p<0.05)SAH causes an inflammatory reaction and may lead to
ischemic brain damage (11). Experimental ischemia has been
shown to be connected with the alarm-reaction cytokines
such as IL-1 Ra and TNF- (11). Increased levels of these
cytokines were detected in patients following SAH event
and correlated with neurological damage. It is likely that
these cytokines, especially IL-1, contribute to experimental
ischemic and traumatic brain injury. IL-6 level were signifi-
cantly increased in patients suffering from a DID, which
may have immunological causes or reflect alterations of the
immune system (10). However, interleukin-1 production
in the CNS following SAH has not been studied. In addi-
tion, initial levels of CSF cytokines including IL-1 , IL-6,
and TNF- as strong candidates contributing to DID have
not been studied. On the basis of the known association of
SAH and various cytokines, this study was undertaken to
investigate whether DID could be predicted by the high
levels of cytokines including IL-1 , IL-6, and TNF- in the
initial CSF following SAH.
The results of this study demonstrated that the majority
of patients with ruptured cerebral aneurysms have increased
cytokine levels in the initial CSF on admission. The levels
of IL-1 , IL-6, and TNF- in CSF were higher in patients
with SAH (n=19) than in healthy volunteers (n=12). In par-
ticular, IL-1 and TNF- levels were significantly increased
in CSF from SAH patients on admission (p=0.000, 0.000,
respectively). However, IL-6 levels showed no statistically
significant difference (p=0.441). A large variation in indi-
vidual IL-6 was revealed. These results could be explained
by the previous report that showed CSF IL-1 and TNF-
levels were increased at early stage of inflammatory cascade
and they induced IL-6 expression in SAH patients (11).
The importance of assessing the neurological condition in
patients with SAH lies in the prediction of outcome (23).
Cytokine production in the CNS following SAH and its
relation with initial neurological condition have not been
studied. The present study revealed that IL-1 and IL-6
levels were markedly elevated in high HHG group (n=3)
than in low HHG group (n=16), but only IL-1 had a sta-
tistical significance (p=0.037). Most patients with good
neurological condition had low levels of IL-1 and IL-6,
while all the patients with poor neurological condition had
high levels of them. HHG relies on less consistent defini-
tion of level of consciousness than does the Glasgow coma
scale (14). The IL-6 is increased in the ventricular fluid of
patients suffering from head injury and the levels correlate
with clinical status (24). It is likely that IL-1 and IL-6 may
be considered to be indicators of initial poor neurological
status after an SAH event.
Focal, thick collections of cisternal blood visualized on a
CT scan are highly predictive of vasospasm (25). The pre-
sent study showed that the levels of IL-1 and TNF- in
low FG group (n=8) were higher than in high FG group
(n=11), and the level of IL-6 in high FG group were higher
than in low FG group without a statistical significance. It is
unlikely that the levels of IL-1 , IL-6, and TNF- in the
initial CSF after SAH correlate with amount of cisternal
blood visualized on a CT scan. However, the relationship
between amount of hemorrhage on a CT scan and cytokine
levels should be further verified with prospective studies in
aneurysmal SAH patients.
Pathogenic role of the immune system in vasospasm and
DID after SAH has been postulated by some authors (1, 8),
while others have failed to reveal its causative role (7). Dif-
ferent mechanisms of the immune system have been believed
to be operative in DID. One of them is based on the obser-
vation that the neopterin values were higher in patients suf-
fering from symptoms of delayed cerebral ischemia (5). This
can be interpreted as signs of ongoing T cell activation both
systemically and in the CSF compartment following SAH.
This study demonstrated that six patients developed DID.
The levels of IL-1 , IL-6, and TNF- were markedly ele-
vated in these patients (n=6) than the patients without DID
(n=13), but only IL-6 levels showed a statistical significance
(p=0.003). A large variation in individual levels of IL-1 and
TNF- was found. Of seven  patients who had levels of IL-
6 higher than 1216.21 pg/mL in the initial CSF, six patients
developed delayed ischemic symptoms and showed a focal
or diffuse infarction on follow-up CT scan. Two patients of
them developed moderate disability and one patient experi-
enced severe disability. Three patients attained good recov-
ery. These results indicate that high level of IL-6 in the ini-
tial CSF on admission after SAH event can predict DID.
Mathiesen et al. (10) reported that IL-6 levels were signifi-
cantly increased in patients suffering from DID following
SAH. The intracerebral levels of IL-6 appeared to be two
peak pattern. First peak is day 3, and second is around day 6
following ictus. The DID, most commonly noticed 4 to 8
days after SAH, follows a similar time course and is frequent-
ly heralded by an increased leukocyte count in peripheral
blood and a low-grade fever. The IL-6 levels were higher on
day 6 than on day 3 and day 9. More recently, they showed
that levels of IL-1 receptor antagonist and TNF- were in-
creased after SAH event and high cytokine levels correlated
with brain damage (11). It is likely that these cytokines,
especially IL-1, contribute to brain damage after SAH event.
Our results showing elevated levels of IL-1 , IL-6, and TNF-
are consistent with their findings, but only IL-6 exhibited
a statistical significance.
Mathiesen et al. (10) also detected significant activation
of the alarm-reaction cytokine system demonstrated by mea-
surements of IL-1Ra and TNF- levels in CSF obtained
from patients suffering from SAH. The results showed that
patients with favorable outcomes had low levels of these
cytokines. This study also showed that the patients with
good GOS (n=14) showed high levels of IL-1 and IL-6 in
the initial CSF, while the patients with poor GOS (n=5)
showed high levels of TNF- in the initial CSF, but with-
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10, 16, and 17) who had poor GOS showed high levels of
IL-6 in the initial CSF after SAH event. Two of them (cases
1, 16) did not show elevation of IL-6 levels and did not devel-
op DID. Two patients, whose IL-6 level was not increased,
but developed DID, showed poor outcomes. One (case 1) of
them had a de novo aneurysmal rupture, followed by mod-
erate disability. Another (case 16) experienced disseminated
intravascular coagulation, which lead to death. It is unlikely
that the levels of these cytokines in initial CSF on admission
after SAH event can predict the outcome. We assume that
the outcome would be determined by multiple factor, e.g,
operative complications, rebleeding, combined medical con-
dition, hydrocephalus, etc. Strong correlations were found
between IL-1 and IL-6 levels in the initial CSF, and neuro-
logical condition on admission, and between IL-6 levels in
the initial CSF on admission and development of DID.
In conclusion, the present study revealed that patients
with aneurysmal SAH on admission exhibited increased
levels of IL-1 and TNF- , and the patients presenting
with poor neurological condition had high levels of IL-1
and IL-6 in their initial CSF. It is likely that high levels of
IL-6 in the initial CSF on admission after SAH event can
predict the high risk of DID. These findings are in support
of the hypothesis that deterioration following SAH may
have immunological causes or reflect alterations of the im-
mune system. However, further corroboration of such hypoth-
esis is needed, and further neuroimmunological research is
necessary to analyze the time course of IL-1 , IL-6, and
TNF- in CNS after SAH event.
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